Hogan Lovells Cadwalader has advised Smith+Nephew. Smith+Nephew, the global medical technology company listed on the London Stock Exchange (LSE: SN) and New York Stock Exchange (NYSE:...
Smith+Nephew Secures FDA De Novo Classification for TESSA Spatial Surgery System
Thermo Fisher to Sell Microbiology Business to Astorg for $1.075 Billion
Cravath, Swaine & Moore LLP, Axinn, Veltrop & Harkrider LLP, Hogan Lovells, and Perella Weinberg Partners and Wells Fargo have advised Thermo Fisher Scientific. Latham &...
Xenex’ FDA De Novo Authorization for UV Microbial Reduction Robot
Hogan Lovells advised Xenex Disinfection Services, Inc. (Xenex). he U.S. Food and Drug Administration has granted Xenex Disinfection Services, Inc. De Novo authorization for the company’s LightStrikeTM+...
Bioretec Ltd’s Obtaining FDA Premarket Authorization for RemeOs Trauma Screw
Hogan Lovells counsels Bioretec in first ever De Novo grant for bioresorbable metal trauma screw. Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, in securing Food...
Lucira Health’s OTC COVID-19 and Flu Test FDA Authorisation
Hogan Lovells counseled Lucira Health, Inc. Lucira Health, Inc. (Lucira), a medical technology company focused on the development of innovative infectious disease tests, secured U.S. Food...